SLC40A1 Knockout HEK293 Cell Line
Cat.No.:
EDC07994
Species:
Human
Cell Name:
HEK293
Gene:
SLC40A1
Gene ID:
30061
Size:
1×10⁶cells
SLC40A1 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07994 |
|---|---|
| Product Name | SLC40A1 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | SLC40A1 |
| NCBI Gene ID | |
| Gene Synonyms | FPN|FPN1|HFE4|IREG1|MST079|MSTP079|MTP1|SLC11A3 |
| Summary |
The protein encoded by this gene is a cell membrane protein that may be involved in iron export from duodenal epithelial cells. Defects in this gene are a cause of hemochromatosis type 4 (HFE4). [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC40A1 function, SLC40A1 Knockout HEK293 Cell Line or SLC40A1 overexpression HEK293 Cell Line?
The choice depends on whether you are studying ferroportin's role as the principal cellular iron exporter or modeling hemochromatosis type 4 and ferroportin disease. The Knockout line is the standard tool for asking whether ferroportin is required for iron efflux — ferroportin is the only known mammalian cellular iron export transporter, expressed on enterocytes, macrophages, and hepatocytes. Overexpression is useful for studying ferroportin in heterologous expression systems and for testing hepcidin-mediated regulation.
For iron homeostasis research, the EDITGENE Ferroportin Knockout in HEK293 is the standard mechanistic platform — HEK293 has been extensively used for ferroportin biochemistry and structural studies. Rescue with wild-type, hepcidin-resistant (C326S), or ferroportin disease-associated mutant SLC40A1 enables comprehensive disease modeling. SLC40A1 mutations cause autosomal dominant hemochromatosis type 4/ferroportin disease — disease variant rescue is a standard genotype-function approach.
What are the application scenarios for this model?
Primary applications:
• Iron efflux assays: ⁵⁹Fe efflux from preloaded cells to quantify ferroportin transport activity.
• Hepcidin-mediated regulation: hepcidin-induced ferroportin internalization and degradation assays — the primary regulatory mechanism for systemic iron homeostasis.
• Disease mutation modeling: rescue with autosomal dominant hemochromatosis type 4-associated SLC40A1 variants (e.g., A77D 'loss-of-function', N144H 'hepcidin-resistant').
• Hepcidin-resistant rescue: C326S mutation creates a hepcidin-resistant ferroportin useful for studying iron export independent of hepcidin regulation.
EDITGENE recommends this model for researchers investigating iron homeostasis, hereditary hemochromatosis, and ferroportin-targeting therapeutic development.
Is this SLC40A1 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. Ferroportin rescue experiments are well-established in iron biology research:
• Construct design: use a codon-modified SLC40A1 sequence with a small C-terminal tag (FLAG, HA). Ferroportin has 12 transmembrane domains — N-terminal tags must not disrupt topology.
• Hepcidin-resistant rescue: the C326S mutation prevents hepcidin binding and creates a hepcidin-insensitive ferroportin — invaluable for studying iron export independent of hepcidin regulation.
• Disease mutation rescue: A77D (classical 'loss-of-function'), N144H, and other hemochromatosis type 4-associated mutations enable disease genotype-function studies.
• Functional readout: rescue should restore ⁵⁹Fe efflux from preloaded cells and hepcidin-induced ferroportin internalization (where wild-type protein is used).
HEK293 transduces efficiently with lentivirus and is the standard heterologous expression background for ferroportin biochemistry and disease modeling.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download